Our two speakers: Professor Jérôme Boursier, from France, and Professor Mazen Noureddin, from United States, will do a review of available literature, present clinical study results and, discuss advantages of these scores versus other noninvasive markers. Then, they will go through two clinical cases to understand how those scores could easily be implemented in your daily clinical practice to enhance management of patients with NAFLD and quickly answer your questions about diagnostic and prognostic.
Comunicado de prensa | 10.11.2024